License-Out
License Agreement between NACALAI TESQUE, INC. and iPS Academia Japan, Inc.
iPS Academia Japan, Inc. has entered into a non-exclusive license agreement with NACALAI TESQUE, INC. (Kyoto, Japan) to provide products and...
results 41 - 50 of 89
License-Out
License Agreement Has Been Entered with aceRNA Technologies
We executed an exclusive worldwide license agreement with aceRNA Technologies Co., Ltd. (Kyoto, Japan) for providing reagents and services f...
License-Out
License Agreement Has Been Entered with Asahi Kasei Corp.
We executed a worldwide license agreement with Asahi Kasei Corp. (Tokyo, Japan) for the use of iPS cell-derived cartilage for regenerative t...
License-Out
License Agreement Has Been Entered with Stem Cell & Device Laboratory, Inc. (SCAD)
We executed a non-exclusive license agreement with SCAD for providing their products related to iPS cell-derived cardiomyocytes for research...
License-Out
License Agreement Has Been Entered with Novoheart Limited
We executed a non-exclusive license agreement with Novoheart Limited (Hong Kong) for providing their products and services related to iPS ce...
License-Out
License Agreement Has Been Entered with IRBM S.p.A.
We have been executed a non-exclusive license agreement with IRBM (Italy) for provision of services using iPS cell-derived cells based on th...
License-Out
License Agreement Has Been Entered into with NEXEL Co., Ltd.
We have entered into a non-exclusive license agreement with NEXEL Co., Ltd. (South Korea), under which NEXEL Co., Ltd. is allowed to sell iP...
License-Out
License Agreement Has Been Entered with Katholieke Universiteit Leuven
We have executed a non-exclusive license agreement with Katholieke Universiteit Leuven (Belgium) for provision of services using iPS cell-de...
License-Out
License Agreement Has Been Entered with iXCells Biotechnologies USA, Inc.
We have executed a non-exclusive license agreement with iXCells Biotechnologies USA, Inc. which provides products and services related to iP...
License-Out
License Agreement Has Been Entered with Platelet Biogenesis, Inc.
We executed a non-exclusive license agreement with Platelet Biogenesis, Inc. (Cambridge, U.S.A.) for the use of iPS cell-derived platelet pr...
